Sarepta Therapeutics | SRPT - 股票

金融业

USD 16.07

USD 3.17B

现金及等价物

USD 472.76M

USD 189.23M

USD 2.27B

USD 656.35M

USD 857.36M

USD -9.04M

USD -3.14M

1.37K

EPS每股收益

USD 0.13

股本和储备

USD 1.53B

USD 192.12M

债务利息支出

USD 21.51M

USD 7.16M

USD 699.39M

USD 1.48B

USD -28.46M

USD 390.39M

USD -9.04M

普通股股本

USD 107.23M

32.09

USD -25.77M

USD 381.4M

销售和管理费用

USD 118.61M

USD 876.12M

贸易债权人

USD 45.7M

应收帐款人

USD 385.98M

	股票	更改		日
Acadia Pharmaceuticals	USD 40.36M		68.31M	2026-09
Agios Pharmaceuticals	USD 37.84M		2.09M	2026-09
Alnylam Pharmaceuticals	USD 105.91M		8.8M	2026-09
Amgen	USD 6.39B		169M	2026-09
BioCryst Pharmaceuticals	USD 13.74M		7.68M	2026-09
Biogen	USD 2.22B		159.9M	2026-09
BioMarin Pharmaceutical	USD 1.8B		13.54M	2026-09
Daiichi Sankyo	JPY 733.05B		40.68B	2026-06
Eli Lilly	USD 18.19B		1.4B	2026-09
Gilead Sciences	USD 1.9B		57M	2026-09
Incyte	USD 134.25M		21.71M	2026-09
Insmed	USD 163.95M		21.56M	2026-09
Ionis Pharmaceuticals	USD 28.58M		22.26M	2026-09
Moderna	USD 313M		33M	2026-09
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Neurocrine Biosciences	USD 66.1M		38.1M	2026-09
Novavax	USD 18.5M		8.49M	2026-09
Pfizer	USD 10.02B		77M	2026-09
PTC Therapeutics	USD 109.33M		17.98M	2026-09
Regeneron Pharmaceuticals	USD 2.89B		189.7M	2026-09
Roche Holding	CHF 7.6B		9M	2025-06
Sanofi	EUR 24.12B		620M	2026-06
Sarepta Therapeutics	USD 876.12M		28.15M	2026-09
Ultragenyx Pharmaceutical	USD 59M		0	2026-09
Vertex Pharmaceuticals	USD 2.25B		480.2M	2026-09